| 摘要 |
<p>The present invention relates to Penta- hexa-, hepta-, octa-, nona- and, deca-heteroaryl derivatives, comprising a combination of heterocycle 1 (Het-1)a and/or heterocycie 2 (Het-2)b and/ or heterocycle 3 (Het-3)c and/or heterocycle 4 (Het-4)d of formulae I, II, III and IV respectively, the N-oxides, the pharmaceutically acceptable addition salts. The compounds claimed are suitable for the treatment of cancer.</p> |
| 申请人 |
INSTITUT CURIE;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS);INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM);MUSEUM NATIONAL D'HISTOIRE NATURELLE (MNHN);NGUYEN, CHI-HUNG;ROUCHON DAGOIS, MYRIAM;GUEDIN-BEAUREPAIRE, AURORE;MONCHAUD, DAVID;TEULADE-FICHOU, MARIE-PAULE;RIOU, JEAN-FRANCOIS;MERGNY, JEAN-LOUIS;GRIERSON, DAVID |
发明人 |
NGUYEN, CHI-HUNG;ROUCHON DAGOIS, MYRIAM;GUEDIN-BEAUREPAIRE, AURORE;MONCHAUD, DAVID;TEULADE-FICHOU, MARIE-PAULE;RIOU, JEAN-FRANCOIS;MERGNY, JEAN-LOUIS;GRIERSON, DAVID |
